Plain-English translation of NCT07064109 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is a research study testing whether colchicine, a low-dose anti-inflammatory medication, can help people recover better after a heart attack when added to their standard treatment. Researchers want to understand how this medication works in the body and identify which patients benefit most from it. Half of participants will receive the medication along with standard care, and half will receive standard care alone.
Heart attacks involve inflammation in the body that can lead to long-term complications. This trial exists to see whether reducing that inflammation with this medication might improve recovery and prevent future heart problems.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either receive the medication added to your standard heart attack treatment, or to continue with standard treatment alone. You will likely have follow-up visits where researchers collect blood samples and other information to understand how well the treatment is working and how your body is responding. The study involves detailed testing to help researchers build a model of who benefits most from this medication.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
China